Last reviewed · How we verify
NCT05433415
Black Girls Move Physical Activity and Improving Dietary Intake Among Black Adolescent Daughters
NA trial testing Black Girls Move in Adolescent Obesity in 120 participants. Participants enrolled and being followed up; not accepting new ones.
30 November 2025
Quick facts
| Lead sponsor | Rush University Medical Center |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 120 |
| Start date | 6 March 2023 |
| Primary completion | 30 November 2025 |
| Estimated completion | 30 May 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Black Girls Move
Conditions studied
- Adolescent Obesity — all drugs for Adolescent Obesity →
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Rush University Medical Center
Who can join
Adults 12 to 18, female only, with Adolescent Obesity or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Black Girls Move is a school-linked daughter/mother physical activity and dietary behavior program, with 9th and 10th grade students. This program is designed to prevent obesity in Black adolescent females and thus aligns with the NIH mission to enhance health, lengthen life, and reduce illness and disability. This project is relevant to public health because it holds the potential to reduce population health disparities impacted by structural racism.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05433415
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adolescent Obesity
Currently open trials in the same condition.
- NCT06616454 — The Effect of Time-Restricted Feeding on Body Composition and Some Metabolic Parameters in Obese Adolescents · NA · recruiting
- NCT06575738 — Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents · Phase 1 · recruiting
- NCT05935826 — Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study) · Phase 3 · recruiting
- NCT06745570 — Improving Sleep, Decision-Making, and Eating in Adolescents with Obesity · NA · active not recruiting
- NCT06208345 — Early Life Intervention in Pediatrics Supported by E-health · NA · recruiting
Other Rush University Medical Center trials
Trials by the same sponsor.
- NCT07278076 — Clinical Decision-Making During FEES: The Impact of Residue Amount and Location · NA · not yet recruiting
- NCT07088120 — PRECISION-CPR: PRecision-Controlled Ventilation in CPR · NA · not yet recruiting
- NCT06894719 — Oral Tranexamic Acid After Total Knee Arthroplasty · Phase 4 · not yet recruiting
- NCT06229392 — A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer · Phase 1 · withdrawn
- NCT07452406 — Protocolized Weaning of High-Flow Nasal Cannula in Adult Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05433415 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rush University Medical Center
- Last refreshed: 5 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05433415.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing